Location History:
- Ansan-si, KR (2014)
- Gyeonggi-do, KR (2016)
Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Soo Heui Paik
Introduction
Soo Heui Paik is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with angiogenesis inhibitory activity. His work has led to the filing of two patents, showcasing his innovative approach to addressing medical challenges.
Latest Patents
Soo Heui Paik's latest patents include a compound having angiogenesis inhibitory activity and an antihypertensive pharmaceutical composition. The first patent discloses an anti-angiogenic compound, represented by Chemical Formula I, which potently suppresses angiogenesis. This compound is applicable for the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, making it a valuable anti-angiogenic agent. The second patent provides an antihypertensive pharmaceutical composition containing Fimasartan and Amlodipine, both of which serve as effective treatments for hypertension.
Career Highlights
Soo Heui Paik is currently associated with Boryung Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in developing effective compounds has positioned him as a key player in the industry.
Collaborations
Throughout his career, Soo Heui Paik has collaborated with talented individuals such as Ji Han Kim and Je Hak Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Soo Heui Paik's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in addressing health challenges.